Epigenomics AG launches the world’s first in vitro diagnostic blood test for early detection of colorectal cancer. Epi proColon is an innovative molecular diagnostic test that can detect tumor derived methylated DNA of the Septin9 gene (mSEPT9) in blood plasma as a reliable indicator, or biomarker, for colorectal cancer.
Read More
CLP talks to Quidel’s new CEO, Douglas Bryant, about advances in respiratory virus testing and his longterm strategies for the company.
Read MoreAccumetrics Inc announces that it has completed a round of financing that will raise $16.5 million in new capital.
Read MoreResearchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.
Read More
AperioApplied Spectral ImagingAtherotechAureon LaboratoriesBiolmageneMilestone MedicalNovovision IncThermo Fisher ScientificVentana Medical Systems
Read More